Latest Litigation News

AMP Limited reported a 9.2% rise in underlying net profit after tax for the first half of 2025, alongside a declared interim dividend, while navigating fresh legal challenges.

Mayne Pharma has firmly rejected a fresh termination notice from Cosette Pharmaceuticals alleging breaches related to FDA disclosure, escalating an ongoing contractual dispute with significant legal implications.

Credit Corp Group delivered a robust FY25 with a 16% increase in net profit after tax, driven by US debt buying and Australian/NZ lending growth. The company sets an ambitious FY26 outlook, underpinned by a record US investment pipeline and new product launches.

Sarama Resources has taken a significant step in its international arbitration against Burkina Faso following the expropriation of its key gold exploration permit. The company seeks at least US$120 million in damages as proceedings move forward.

Noumi Limited reported a nearly flat Q4 FY25 revenue with mixed segment performances and flagged a net loss for the year amid legacy legal expenses. The company highlights growth in its Milklab brand and export sales while managing significant convertible note obligations.

Winchester Energy reported steady oil production and revenue for the June quarter while resolving key legal disputes and undergoing significant board changes. The company also withdrew from costly Peruvian exploration plans, focusing on US operations and cost control.

Equity Story Group has secured a transformative deal to acquire Baker Young Limited, significantly expanding its wealth advisory footprint and boosting revenue projections by over 400%. Meanwhile, its Growth Fund outperforms benchmarks and a new litigation funding vehicle launches.

Ovanti Limited has appointed Peter Maher, a seasoned BNPL executive from Zip Co, to lead its US expansion, while exploring a NASDAQ listing via dual-listing or SPAC merger and reconsidering the sale of a key dividend-yielding asset.

Atomos Limited faced a challenging Q4 FY25 with US tariff disruptions but rebounded strongly in June, launching new products and appointing Peter Barber as CEO to drive future growth.

Zuleika Gold Limited has scheduled a pivotal trial in October 2025 to resolve damages claims against Catalyst Metals Limited, while advancing exploration plans at its key Western Australian projects.

Next Science reports a 10% decline in quarterly product sales but advances a $50 million asset sale to Demetra Holdings, signaling a pivotal shift in its business strategy.

Omni Bridgeway Limited has reported record investment proceeds of A$555.5 million for FY25, underpinned by robust completions and a growing pipeline. Positive regulatory shifts in key markets further bolster the company’s outlook.